In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Kosuke Takada *Department of Molecular Virology, Research Institute for Microbial Diseases, the University of Osaka, Suita, Osaka, 565-0871, Japan. k-takada@biken.osaka-u.ac.jp.ORCID 0009-0002-7951-8402 Nicholas Yamahoki *Department of Molecular Virology, Research Institute for Microbial Diseases, the University of Osaka, Suita, Osaka, 565-0871, Japan.ORCID 0000-0002-1225-4732 Jonathon C O MifsudDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
Itsuki AnzaiDepartment of Molecular Virology, Research Institute for Microbial Diseases, the University of Osaka, Suita, Osaka, 565-0871, Japan.ORCID 0000-0001-9307-943X Tadashi MaemuraInfluenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Francisco Borges CostaDepartment of Pathology, Postgraduate Program in Animal Science (PPGCA), State University of Maranhão (UEMA), São Luís, Maranhão, Brazil.ORCID 0000-0002-6923-7183 Eric Takashi Kamakura de Carvalho MesquitaDepartment of Pathology, Postgraduate Program in Animal Science (PPGCA), State University of Maranhão (UEMA), São Luís, Maranhão, Brazil.ORCID 0000-0002-4481-0422 Mateus de Souza Ribeiro MioniDepartment of Pathology, Reproduction and One Health, São Paulo State University (UNESP), Jaboticabal, São Paulo, Brazil.ORCID 0000-0001-7886-1570 Tiago J S LopesDivision of Virology, Department of Microbiology and Immunology and International Research Center for Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
Yoshihiro KawaokaInfluenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-5061-8296 Jane MegidDepartment of Animal Production and Preventive Veterinary Medicine, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
Tokiko WatanabeDepartment of Molecular Virology, Research Institute for Microbial Diseases, the University of Osaka, Suita, Osaka, 565-0871, Japan. tokikow@biken.osaka-u.ac.jp.ORCID 0000-0002-8242-7539 Funding
Department of Health | National Health and Medical Research Council (NHMRC) GNT2017197Japan Agency for Medical Research and Development (AMED) 22gm1610010h0001Japan Agency for Medical Research and Development (AMED) JP19fk0108113Japan Agency for Medical Research and Development (AMED) JP19fk018113Japan Agency for Medical Research and Development (AMED) JP20wm0125002Japan Agency for Medical Research and Development (AMED) JP223fa627001Japan Agency for Medical Research and Development (AMED) JP223fa627002Japan Agency for Medical Research and Development (AMED) JP22am0401030Japan Agency for Medical Research and Development (AMED) JP23fk0108659MEXT | Japan Society for the Promotion of Science (JSPS) 16H06429MEXT | Japan Society for the Promotion of Science (JSPS) 16H06434MEXT | Japan Society for the Promotion of Science (JSPS) 16K21723MEXT | Japan Society for the Promotion of Science (JSPS) 21J01036MEXT | Japan Society for the Promotion of Science (JSPS) 22K15469MEXT | Japan Society for the Promotion of Science (JSPS) 25K18814MEXT | Japan Society for the Promotion of Science (JSPS) 25KK0093MEXT | Japan Society for the Promotion of Science (JSPS) JP22H02521
6 · The paper itselfAbstract
Bats are natural reservoirs for a wide range of RNA viruses. Members of the genus Betacoronavirus, including Severe Acute Respiratory Syndrome virus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome virus (MERS-CoV), have attracted particular attention due to their recent zoonotic emergence. However, much of the known diversity of betacoronaviruses is based on data from Asia, Africa, and Europe, with limited genomic information available from the Americas. Herein, we report the complete genome of a betacoronavirus identified from a Pteronotus parnellii bat sampled in Brazil. Phylogenetic analysis reveals that this virus is sufficiently distinct from the five recognized Betacoronavirus subgenera to represent a new subgenus. Of note, the spike protein of this bat coronavirus possesses a functional furin cleavage site at the S1/S2 junction with a distinct amino acid sequence motif (RDAR) that differs from that found in SARS-CoV-2 (RRAR) by only one amino acid. Comparative structural analysis identifies other betacoronaviruses in bats with furin cleavage sites at the S1/S2 junction, suggesting that this region is a structurally permissive "hotspot" for cleavage site incorporation. Our study provides a broader understanding of the phylogenetic and functional diversity of bat coronaviruses, offering evolutionary context for features that may be relevant to zoonotic potential.
Indexed as
BetacoronavirusChiropteraFurinAmino Acid SequenceAnimalsBrazilGenome, ViralPhylogenySpike Glycoprotein, CoronavirusFurinSpike Glycoprotein, Coronavirus
Identifiers
PMID42838974
PMCPMC13642304
What OpenQuestion holds
Textmetadata
Read underepoch 390